Investors Support Phage Therapy
Novel Approach to Solve The Antibiotics Crisis Receives Further Millions
01-Jul-2019 -
Austrian biotech company PhagoMed Biopharma GmbH (PhagoMed) successfully completed another financing round. PhagoMed, located at the Vienna Biocenter, is focused on developing virus-(phage-) based therapies against drug-resistant and chronic bacterial infections. Investors provided further €1.5 ...
antibiotic resistance
financing
phage-based therapies
+1